Improving Acute and Preventive Treatment of Migraine in the Primary Care Setting Using Novel Agents

Improving Acute and Preventive Treatment of Migraine in the Primary Care Setting Using Novel Agents is organized by Med Learning Group and will be held from Dec 17, 2018 - Dec 17, 2019.

Target Audience:
This educational activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 1.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.25 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AOA Credit: The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this enduring program for a maximum of 1.25 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this online activity.

Description:
This case-based enduring activity will cover the treatment and management of patients with migraines.

Learning Objectives:
Upon completion of the CME activity, learners should be better able to:
• Review best practices for diagnosing migraine headaches including the process of differential diagnosis
• Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
• Describe burdens associated with migraine headaches and the use of patient reported outcomes for measuring the impact of new and established migraine therapies
• Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice.

 Additional details will be posted as soon as they are available.